Product Shortages from Guidelines To Practice: Considerations And Strategies For Management

Lecture of the Month CE Activity Overall Goal:

This CE activity serves to promote the process of life-long learning for physicians, dietitians, pharmacists, and nurses who specialize in the sciences of clinical nutrition and metabolism.

Goal and Target Audience:

This educational activity is directed toward clinical nutrition and metabolism professionals and others who wish to update their knowledge of clinical nutrition and metabolism. By participating in this educational activity, the reader may expect to:

• Acquire knowledge in the area of clinical nutrition and metabolism research
• Update or confirm your understanding of appropriate clinical nutrition and metabolism practices.
• Identify further learning needs as they relate to the subject matter.

Learning Objectives:

1. Review drug shortages and describe A.S.P.E.N.’s response to parenteral nutrition product shortage alerts
2. Identify recommendations for managing parenteral nutrition product shortages
3. Identify unique strategies for management of the neonatal and pediatric patient during product shortages
4. Analyze factors to consider with product interchanges
5. Discuss proactive approaches to resource management for the home nutrition support patient

Requirements for Successful Completion:
To obtain CE credit for this activity, attendees must listen to the education recording, complete an online knowledge assessment for each education recording and achieve a score of 100%, and complete an online activity evaluation. All CE credit must be claimed prior to the expiration date.

Accreditation Statements/Continuing Education Credit:

Nurses
A.S.P.E.N. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

A.S.P.E.N. is approved by the California Board of Registered Nursing, Provider CEP 3970, for 1.5 contact hours per lecture in the lecture of the month series.

Pharmacists
A.S.P.E.N. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN: 0216-0000-14-058-H05-P
Knowledge activity.

Dietitians
A.S.P.E.N., Provider Number AM005, is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR level 2. Dietitians may post comments on this program on www.cdrnet.org.

PhysiciansProvider 0002345
A.S.P.E.N. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

A.S.P.E.N. designates this enduring material for a maximum of 1.5AMA PRA Category 1 Credits™ per lecture. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policies/Information:
Non-Commercialism: A.S.P.E.N. subscribes to the ACCME Standards for Commercial Support. A.S.P.E.N. does not provide programs that constitute advertisement or include promotional materials. A.S.P.E.N. does not endorse any products.

Privacy and Confidentiality: A.S.P.E.N. respects the privacy of its members and website visitors. Companies that receive personal information from A.S.P.E.N. in order to execute the business of A.S.P.E.N. may use personal information only for that purpose.

Refund Policy: Refunds are not available.

Grievances: Grievances must be submitted in writing to Director of Education at A.S.P.E.N. 8630 Fenton Street. Suite 412. Silver Spring, MD 20910.

Commercial Support and Sponsorship: No commercial support or sponsorship has been received for this enduring continuing education activity.

Commercial Relationships Disclosures and Conflicts of Interest (COI) of Faculty

Karrie Derenski- Sanofi Aventis, Baxter, and Abbott, honoraria, speaker: Conflict resolved through altering the topic so that it does not include practice recommendations, but addresses only the evidence-based science. Beverly Holcombe: No Disclosures. Allison Blackmer: No Disclosures. Carol Rollins: No Disclosures. Michael Kraft: No Disclosures.